STATE-LEVEL VARIABILITY IN HPV VACCINE COVERAGE IN BRAZIL FROM 2018 THROUGH THE COVID-19 PANDEMIC IN 2020 (ID 652)

Presenter
Authors

Previous ePoster
A NATIONWIDE CROSS-SECTIONAL SURVEY ON KNOWLEDGE, ATTITUDE AND PRACTICE TOWARDS HUMAN PAPILLOMAVIRUS (HPV) VACCINE IN CHINESE DURING COVID-19 PANDEMIC (ID 490)

Next ePosters
DISRUPTION TO ADOLESCENT WELL VISITS AND HPV VACCINATIONS DURING THE COVID-19 PANDEMIC (ID 828)
COMPASS-PLUS: EVALUATING THE IMPACT OF COVID-19 ON ATTENDING PRIMARY HPV SCREENING WITHIN THE AUSTRALIAN CERVICAL SCREENING PROGRAM (ID 300)
HOME-BASED SELF-SAMPLING OF FIRST-VOID URINE AS A VALUABLE AND ACCESSIBLE HPV SCREENING METHOD DURING AND AFTER THE COVID-19 PANDEMIC. (ID 344)
PILOT PLAN OF THE HEALTH NAVIGATOR STRATEGY IN A PREVENTION PROGRAM FOR CERVICAL CANCER CONTROL WITH HPV SCREENING IN CORDILLERA-PARAGUAY DURING THE COVID-19 PANDEMIC (ID 379)
FEAR OF COVID-19 IS ASSOCIATED WITH INCREASED WORRY ABOUT ANAL CANCER AMONG SEXUAL AND GENDER MINORITIES (ID 382)
EXPLORING ACCEPTABILITY OF ANAL SWABS SELF-COLLECTED FOR CYTOLOGY IN HIGH-RISK POPULATIONS DURING THE COVID-19 PANDEMIC IN THE DOMINICAN REPUBLIC: A PILOT ASSESSMENT STUDY (ID 486)
CONSULTATIONS DURING COVID-19 IN A PRIMARY HEALTHCARE CENTER: PRACTICAL EXPERIENCES FOR THE FUTURE (ID 71)
UNDERSTANDING WOMEN’S PERSPECTIVES ON CERVICAL CANCER: KNOWLEDGE, ATTITUDES AND PRACTICES IN LAOS AND SINO-BURMA BORDER AREAS (ID 131)
CERVICAL SELF-SAMPLING TO EARLY DETECT ENDOMETRIAL CANCER: AN ACCEPTABILITY STUDY (ID 134)
THE COST-EFFECTIVENESS OF HUMAN PAPILLOMAVIRUS VACCINATION IN THE PHILIPPINES (ID 137)